GLP — Sözalt

Ozempic can change your body. Can it change your life? science

From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs health

‘I’m sick of her talking about it’: 11 readers share how GLP-1s have affected their relationships health

Americans’ demand for ‘protein-maxxing’ isn’t slowing down as GLP-1s sweep country world

Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work? science

Mind over metabolism: a systematic review of GLP-1 receptor agonists in the treatment of stress-related disorders science

Could GLP-1 Drugs Help Us Live Longer? New Study Shows Promise politics

GLP-1 use in kids under-12 soars - even without FDA approval world

Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%? finance

Victoria's Secret stock soars nearly 300% as GLP-1 weight-loss drugs help reshape lingerie buying habits finance

Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify health

GLP-1 maker hit with 'sell' rating as 2027 revenue cliff fears mount finance

How GLP-1 Sales Could Play Out for Hims & Hers finance

Will muscle-boosting meds be the next big thing after GLP-1 drugs? science

New daily diabetes pill that helps with weight loss launches in UK pharmacies world

Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify health

Big Food Stocks Suffer From GLP-1 Indigestion. Find Bargains in PepsiCo and Smucker. finance

Can weight-loss drugs lose their nasty side effects? finance

US man posed as doctor in fraudulent scheme to profit from Ozempic, prosecutors say world

‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs world